ProfessorRolandVeltkamp

Faculty of Medicine, Department of Medicine

Professor of Neurology and Chair of Stroke Medicine

Contact

Location

3 East6East WingCharing Cross Campus

Summary

Roland Veltkamp received his clinical training as a stroke neurologist in Heidelberg, Germany, and at Wake Forest University School of Medicine, USA. His research interests encompass emergency therapy of ischemic and hemorrhagic stroke and stroke prevention in atrial fibrillation. His research has led to new methods of Afib detection on the stroke unit and to the improvement of acute stroke management in patients on anticoagulants. His translational stroke research group investigates the role of the immune system after stroke. In a landmark study, his group has described a major protective role of regulatory T cells in experimental stroke. Recent findings in his laboratory have led to a phase II clinical stroke trial testing the effect of the leukocyte adhesion blocker natalizumab in stroke.

Currently, Prof. Veltkamp serves as a member of the Board of Directors of the European Stroke Organisation and is an international delegate of the program committee of the AHA International Stroke Conference.

Publications

Journals

Haeusler KG, Groeschel K, Koehrmann M, et al.Haeusler KG, Groeschel K, Koehrmann M, Anker SD, Brachmann J, Boehm M, Diener H-C, Doehner W, Endres M, Gerloff C, Huttner HB, Kaps M, Kirchhof P, Nabavi DG, Nolte CH, Pfeilschifter W, Pieske B, Poli S, Schaebitz WR, Thomalla G, Veltkamp R, Steiner T, Laufs U, Roether J, Wachter R, Schnabel R close, 2018, Expert opinion paper on atrial fibrillation detection after ischemic stroke, Clinical Research in Cardiology, Vol:107, ISSN:1861-0684, Pages:871-880

Purrucker JC, Wolf M, Haas K, et al.Purrucker JC, Wolf M, Haas K, Siedler T, Rizos T, Khan S, Heuschmann PU, Veltkamp R close, 2018, Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants, Acta Neurologica Scandinavica, Vol:138, ISSN:0001-6314, Pages:163-169

Charidimou A, Shams S, Romero JR, et al.Charidimou A, Shams S, Romero JR, Ding J, Veltkamp R, Horstmann S, Eiriksdottir G, van Buchem MA, Gudnason V, Himali JJ, Gurol ME, Viswanathan A, Imaizumi T, Vernooij MW, Seshadri S, Greenberg SM, Benavente OR, Launer LJ, Shoamanesh A close, 2018, Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1), International Journal of Stroke, Vol:13, ISSN:1747-4930, Pages:454-468

Hart RG, Sharma M, Mundl H, et al.Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon B-W, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, Basson MMDV, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ close, 2018, Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source, New England Journal of Medicine, Vol:378, ISSN:0028-4793, Pages:2191-2201

Kasner SE, Lavados P, Sharma M, et al.Kasner SE, Lavados P, Sharma M, Wang Y, Wang Y, Davalos A, Shamalov N, Cunha L, Lindgren A, Mikulik R, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi R, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni DS, Bereczki D, Uchiyama S, Ntaios G, Yoon B-W, Brouns R, Basson MMD, Endres M, Muir K, Bornstein N, Ozturk S, O'Donnell M, Mundl H, Pater C, Weitz J, Peacock WF, Swaminathan B, Kirsch B, Berkowitz SD, Peters G, Pare G, Themeles E, Shoamanesh A, Connolly SJ, Hart RG close, 2018, Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial, Journal of Stroke & Cerebrovascular Diseases, Vol:27, ISSN:1052-3057, Pages:1673-1682

More Publications